A Phase 3 interventional study of Vitamin E and Standard dressing in Surgical Site Infection, sponsored by Hospital General Universitario Elche. Status unknown at 1 site in Spain. Per ClinicalTrials.gov, last updated 2018-02-22.
Sponsored by Hospital General Universitario Elche · Phase 3, Interventional, and Prevention
Among 43 studies in Surgical Wound Infection with a site in Spain — 6 open to participants now, 6 under way, 1 of them phase 3. Surgical Wound Infection · Spain.
Among the 43 studies in Surgical Wound Infection with a site in Spain, this one is the 18th largest by planned enrollment of the 24 interventional ones that give a count, is one of 8 that started in 2018, is one of 5 in phase 3, and was the 11th registered.
746 studies on the registry are indexed under Surgical Wound Infection; 151 are open to participants now.
Browse Surgical Wound Infection studies →6 of the 43 studies in Surgical Wound Infection with a site in Spain are open now. Recruiting first, the newest first:
Hospital de Granollers · Sites in Spain
Ages 18+
Hospital de Granollers · Sites in Spain
Ages 18+
Universitat de les Illes Balears · Sites in Spain
Ages 18+
Aesculap AG · Sites in Spain, Italy
Ages 18+
Hospital de Granollers · Sites in Spain
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 84 Surgical Wound Infection studies recruiting now, 60 (71%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
43 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 6 · Phase 4 4
First in 2007; this study’s year is marked. 8 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is below the median of 200 across 581 interventional studies indexed under Surgical Wound Infection.
Median enrollment 224 across the 24 interventional studies, 1,000 across the 19 observational. Of the 27 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 43 have an industry lead sponsor. The 10 most frequent:
Hospital General Universitario Elche is the lead sponsor of 44 studies on the registry; none are open to participants now.
Hospital General Universitario Elche has 6 studies filed under Surgical Wound Infection — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 43 studies in Surgical Wound Infection with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
A prospective, randomized study will be performed. Patients are randomized using a 1:1 allocation into 2 groups: patients receiving a vitamin E-containing dressing (group 1) and a conventional dressing (group 2). The primary outcomes variable will be occurrence of incisional SSI. Follow-up will be 30 days postoperatively.
A prospective, randomized study will be performed. Patients are randomized using a random number table into 1:1 allocation into 2 groups: patients receiving a vitamin E-containing dressing (group 1) and a conventional dressing (group 2). In group 1 the wound will be covered with a Vitamin E embebbed gauze and plastic adhesive tape. In Group 2, , the wound will be covered with standard gauze and plastic adhesive tape.
The primary outcomes variable will be occurrence of incisional SSI, defined by CDC criteria. Follow-up will be 30 days postoperatively.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients will receive a Vitamin E-containing dressing over the wound
Drug: Vitamin E
Patients will receive a standard dressing over the wound
Drug: Standard dressing
The applied dressing will be embebbed in Vitamin E
Also known as: Exerimental group
The applied dressing is a normal one without adding any product to it.
Also known as: Control group
Incisional surgical site infection
Patients present a wound with the CDC criteria for SSI
Time frame: 30 days postoperatively
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2018 (actual). Primary completion is estimated for Mar 2018, 2 months after the start.
Of 38 phase 3 interventional studies under Surgical Wound Infection, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 51. This study's planned 2 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Vitamin E
Hospital General Universitario Elche